Parkinson Disease study: Dual-Task Training
Official title Effects of Dual-Task Training on Upper Extremity Function in Parkinson's Disease
ClinicalTrials.gov ID: NCT07536542
What this study is testing
- What it's testing
- The researchers want to find out if doing two tasks at once during exercise improves arm function and muscle size in people with Parkinson's disease.
- Who it's for
- This study is looking for adults who have been diagnosed with Parkinson's disease.
- What's involved
- Participants will be assigned to either a group that does special exercises or a group that receives standard care. Everyone will have their arm strength and muscle size measured at the start and end of the study.
- Time commitment
- The study lasts 8 weeks, with exercise sessions three days per week for the training group.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 40 to 65
You may be able to join if
- Diagnosis of idiopathic Parkinson's disease confirmed by a neurologist
- Modified Hoehn and Yahr stage 2 to 3
- No medication or dosage change within the last 6 months
- Cognitive capacity sufficient to understand and follow instructions, defined as Montreal Cognitive Assessment score ≥21
- Voluntary participation with written informed consent
You likely can't join if
- Atypical or secondary parkinsonism
- Advanced orthopedic condition affecting the upper extremity
- Surgery, trauma, or immobilization involving the upper extremity within the last 6 months
- Wound or dermatological condition preventing upper extremity ultrasonographic evaluation
- Severe visual or hearing loss
- Severe depression, psychosis, or communication difficulty
See the full eligibility criteria
- Diagnosis of idiopathic Parkinson's disease confirmed by a neurologist
- Modified Hoehn and Yahr stage 2 to 3
- No medication or dosage change within the last 6 months
- Cognitive capacity sufficient to understand and follow instructions, defined as Montreal Cognitive Assessment score ≥21
- Voluntary participation with written informed consent
- Atypical or secondary parkinsonism
- Advanced orthopedic condition affecting the upper extremity
- Surgery, trauma, or immobilization involving the upper extremity within the last 6 months
- Wound or dermatological condition preventing upper extremity ultrasonographic evaluation
- Severe visual or hearing loss
- Severe depression, psychosis, or communication difficulty
- Any additional health problem preventing regular participation in the study
The study team makes the final eligibility decision.
Where it is enrolling
- Ankara, Turkey (Türkiye)
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 40 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Ankara, Turkey (Türkiye). Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.